Invasive Streptococcus pyogenes (group A Streptococcus, GAS) infections are associated with high morbidity, mortality, and financial costs. 1 Reports of increasing incidence in Australia 2 and overseas 3 justify the surveillance of GAS infections. Contemporary estimates of disease burden are essential for assessing the value of GAS vaccine candidates 4 and for policies regarding post-exposure prophylaxis for close contacts of people with GAS infections. 5 In Australia, invasive GAS infections are notifiable only in Queensland (incidence [2019], 6.7 cases per 100 000 population 6 ) and the Northern Territory (incidence [2018], 31.2 cases per 100 000 population 7 ). It was recently estimated that the overall incidence of invasive GAS disease in Australia during 2017-18 was 8.3 cases per 100 000 population, 2 but it is higher among Indigenous Australians; the estimated incidence in the Northern Territory (2011-2013) was 69.7 cases per 100 000 population. 8 Western Australia is the largest Australian state, covering about one-third of the continent; the population was 2.6 million people in 2018 (10% of the Australian population), including about 2 million living in the capital, Perth, and 4% of the population were Indigenous Australians. 9,10 The climate ranges from tropical in the north, desert in the central regions, to temperate in the south. The climate of the Kimberley and Pilbara regions is tropical, and the proportion of Indigenous people is higher here than in other WA regions (2016: Kimberley, 42%; Pilbara, 14%). 11 Regional, climate-based, and demographic variation in healthrelated variables can accordingly be explored in WA, as in our previous investigation of lower leg cellulitis, based on linked hospital and emergency department data. [12][13][14] Differences between Indigenous and non-Indigenous Australians in GAS disease burden have previously been reported. 2 In this investigation, we quantified the burden of invasive GAS infections in WA during 2000-2018 in terms of incidence, length of hospital stay, and all-cause mortality for the two population groups.
MethodsThe reporting of our population-based data linkage study conforms with the Reporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. 15
Data sourcesThe WA Data Linkage System used best practice methods 16 to link the Hospital Morbidity Data Collection (HMDC; comprising all WA public and private hospital records), PathWest pathology data (PathWest is the government-owned pathology services provider for metropolitan and regional public hospitals), and death registrations. The linked data included a non-identifying number for each included person.
Selection of casesWe analysed data for cases of GAS infection during 1 January 2000 -31 December 2018. Microbiologically confirmed cases